Sharan K Bagal

7PUBLICATIONS
22CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesMolecular medicineNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 16, 2026
Discovery of CNS Penetrant SOS1 Inhibitors for the Treatment of KRAS-Dependent Cancers.

|Jan 30, 2026
Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate Cancer.

James S Scott, Laura Evans, Peter C Astles

|Oct 15, 2025
Focused Structure-Based Virtual Screening Identifies Novel Inhibitors of SOS1.

Silvia Bonomo, Floriane Gibault, Sharan K Bagal

|Jul 11, 2024
Discovery of a Series of Orally Bioavailable Androgen Receptor Degraders for the Treatment of Prostate Cancer.

Sharan K Bagal, Peter C Astles, Coura Diène

|Nov 22, 2021
Diverse, Potent, and Efficacious Inhibitors That Target the EED Subunit of the Polycomb Repressive Complex 2 Methyltransferase.

Sharan K Bagal, Clare Gregson, Daniel H O' Donovan

|Jun 27, 2018
Discovery of Potent, Selective, and Peripherally Restricted Pan-Trk Kinase Inhibitors for the Treatment of Pain.

Sharan K Bagal, Mark Andrews, Bruce M Bechle

Pageof 2

Frequent Collaborators

4 joint publications

Coura R N Diène

3 joint publications

Doyle J Cassar

2 joint publications

Argyrides Argyrou

2 joint publications

Andy Pike